FdaApplication
ANDA 216332
Identifiers
- fda_app_no: ANDA216332
Properties
| Property | Value |
|---|---|
| applicant_name | LAURUS LABS LTD |
| application_type | ANDA |
| approval_date | 2022-07-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABACAVIR SULFATE AND LAMIVUDINE | ABACAVIR SULFATE; LAMIVUDINE | EQ 600MG BASE;300MG | TABLET;ORAL |
1 product